Literature DB >> 22996772

[A questionnaire survey about hair loss after chemotherapy for breast cancer].

Yukiko Oshima1, Takanori Watanabe, Saki Nakagawa, Ayako Endo, Chizuko Shiga.   

Abstract

Hair loss is one of the most common side effects of chemotherapies such as FEC and taxane, and it greatly affects quality of life. We conducted a questionnaire survey of breast cancer patients who were treated with adjuvant chemotherapy about their hair loss. Eighty-five patients participated. They all had lost their hair and suffered from persistent changes in their hair condition, ranging from thinning to curly. More than 80% of patients had worn wigs until their hair had grown back. Furthermore, a few patients did not remove their wigs for 2 years after treatment. Unfortunately, there is no prevention or medication to combat hair loss due to chemotherapy at present, so cumulative examinations are awaited. We must provide appropriate information and support to the patient.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22996772

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  1 in total

1.  A multicenter survey of temporal changes in chemotherapy-induced hair loss in breast cancer patients.

Authors:  Takanori Watanabe; Hiroshi Yagata; Mitsue Saito; Hiroko Okada; Tamiko Yajima; Nao Tamai; Yuko Yoshida; Tomoko Takayama; Hirohisa Imai; Keiko Nozawa; Takafumi Sangai; Akiyo Yoshimura; Yoshie Hasegawa; Takuhiro Yamaguchi; Kojiro Shimozuma; Yasuo Ohashi
Journal:  PLoS One       Date:  2019-01-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.